Mumbai : Suven Life Sciences is currently trading at Rs. 268.25, up by 2.00 points or 0.75% from its previous closing of Rs. 266.25 on the BSE. The scrip opened at Rs. 266.95 and has touched a high and low of Rs. 269.45 and Rs. 266.80 respectively. So far 570 shares were traded on the counter. The BSE group ‘A’ stock of face value Rs. 1 has touched a 52 week high of Rs. 337.70 on 11-Sep-2018 and a 52 week low of Rs. 176.75 on 26-Apr-2018.
Last one week high and low of the scrip stood at Rs. 280.35 and Rs. 260.35 respectively. The current market cap of the company is Rs. 3388.90 crore. The promoters holding in the company stood at 60.00% while Institutions and Non-Institutions held 8.15% and 31.85% respectively.
Suven Life Sciences has completed the purchase of the assets of Rising Pharmaceuticals and Rising’s subsidiaries to Shore Suven Pharma, Inc. This brings closure of the purchase process for the assets of Rising Pharmaceuticals and paves the way for a seamless transition of the portfolio, customer programs and manufacturing and drug development relationships to Shore Suven Pharma Inc.
Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.